Tilmann Buerckstuemmer

Title: The Innovations of Tilmann Buerckstuemmer

Introduction

Tilmann Buerckstuemmer is a notable inventor based in Vienna, Austria. He has made significant contributions to the field of biotechnology, particularly in the development of innovative cell lines and gene therapy techniques. With a total of 5 patents, his work has the potential to impact various medical applications.

Latest Patents

Buerckstuemmer's latest patents include a somatic haploid human cell line. This invention provides for a somatic fully haploid, karyotypically stable human cell line, which can be obtained by targeted deletion of one or more disomic chromosomal regions of a somatic near-haploid human parental cell. The method of producing this cell line, as well as its use for producing isogenic cell variants with genomic mutations at different target sites, showcases his innovative approach. Another significant patent involves adeno-associated viral vectors for gene therapy. This patent details genetically modified compositions, such as adeno-associated viral vectors and primary cells, aimed at treating various conditions and diseases, including cancer.

Career Highlights

Throughout his career, Buerckstuemmer has worked with several prominent companies, including Horizon Discovery Limited and Intima Bioscience, Inc. His experience in these organizations has allowed him to further develop his expertise in biotechnology and innovation.

Collaborations

Buerckstuemmer has collaborated with notable individuals in his field, including Thomas Henley and Mavis Agbandje-McKenna. These collaborations have contributed to the advancement of his research and inventions.

Conclusion

Tilmann Buerckstuemmer's contributions to biotechnology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in gene therapy and cell line development.